ATP
The ATP Group, based in Hillerød, Denmark, is a privately owned asset management holding company that manages ATP Lifelong Pension and oversees pension, investment, and hedging activities. Established by law in 1964, ATP operates as a self-governing institution with a Board of Directors comprising equal representatives of employers and employees, along with an independent chairman. The company employs approximately 3,000 people and has customer service centers across Denmark and offices in Copenhagen and New York. ATP's subsidiaries manage pension funds and invest in various markets, including public and private equity, fixed income, and alternative investments. The organization's investment portfolio includes infrastructure, private debt, private equity, real estate, government and mortgage bonds, listed equities, and inflation-related instruments, reflecting a diversified approach to asset management and administration of social security and welfare benefits on behalf of the Danish state and local authorities.
Veo Technologies ApS, founded in 2015 and based in Copenhagen, Denmark, specializes in camera mount and video technology designed specifically for football. The company provides a solution that allows clubs, players, coaches, scouts, families, and fans to automatically record, edit, and share football matches without the need for a cameraman. Veo's technology offers a user-friendly setup that facilitates the analysis of training sessions and the sharing of highlights, thereby enhancing the experience of watching and engaging with the sport.
MedTrace Pharma A/S is a Danish company focused on enhancing medical imaging through innovative technology. Founded in 2015 and headquartered in Kongens Lyngby, with additional offices in Boston and Uppsala, the company develops an automated system for producing radioactive water, specifically 15O-water, used in positron emission tomography (PET) scans. This system, known as MT-100, automates both the bedside production and infusion of the tracer, significantly increasing the sensitivity of patient analysis and improving throughput by up to four times compared to existing methods. MedTrace also offers aQuant, an analytical software platform designed to interpret PET scan results, further advancing the accuracy and efficiency of clinical diagnostics.
Visiopharm A/S provides AI-based image analysis and tissue mining tools for the pathology industry. It offers end-to-end digital pathology systems solution; Oncotopix scanner, which captures digital images of slides; and APP center, which is a suite of ready to use AI-based apps for diagnostic and clinical research purposes. The company also offers an image analysis software which features Visiopharm Viewer, which enables advanced image analysis and display of field-of-view images; AI Phenotyping module, which automates analysis workflow of image data; Tissuealign module, which enables alignment and analysis of digitalized serial sections; Tissuearray, which assists non-pathologists to undertake technical analysis and test scientific hypoyhesis; VirtualDoubleStain, which automates stroma separation; and Stereotopix, a sterelogy solution. The company provides its products and services through distributers in Europe, North America, Latin America, Asia and Australia. Visiopharm A/S was founded in 2001 and is based in Horsholm, Denmark, with additional offices in Germany, Sweden, the United Kingdom, and USA.
Visiopharm A/S provides AI-based image analysis and tissue mining tools for the pathology industry. It offers end-to-end digital pathology systems solution; Oncotopix scanner, which captures digital images of slides; and APP center, which is a suite of ready to use AI-based apps for diagnostic and clinical research purposes. The company also offers an image analysis software which features Visiopharm Viewer, which enables advanced image analysis and display of field-of-view images; AI Phenotyping module, which automates analysis workflow of image data; Tissuealign module, which enables alignment and analysis of digitalized serial sections; Tissuearray, which assists non-pathologists to undertake technical analysis and test scientific hypoyhesis; VirtualDoubleStain, which automates stroma separation; and Stereotopix, a sterelogy solution. The company provides its products and services through distributers in Europe, North America, Latin America, Asia and Australia. Visiopharm A/S was founded in 2001 and is based in Horsholm, Denmark, with additional offices in Germany, Sweden, the United Kingdom, and USA.